Patents Assigned to Omni Bioceutical Innovations, Inc.
  • Patent number: 11376231
    Abstract: Compositions with fulvate fractions alone or in combination with growth factors, bioactive fragmented peptides, or combinations thereof are disclosed herein. Also disclosed are methods of using said compositions for the catalyzing cellular regeneration, including the healing, treatment, or prevention of skin disorders. Also disclosed are methods for extracting, isolating, and purifying fulvate fractions for use in the manufacture of said compositions.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: July 5, 2022
    Assignee: OMNI BIOCEUTICAL INNOVATIONS, INC.
    Inventors: Gary W. Black, Jane Christensen, Farhan Taghizadeh
  • Patent number: 9820953
    Abstract: Compositions with fulvate fractions alone or in combination with growth factors, bioactive fragmented peptides, or combinations thereof are disclosed herein. Also disclosed are methods of using said compositions for the catalyzing cellular regeneration, including the healing, treatment, or prevention of skin disorders. Also disclosed are methods for extracting, isolating, and purifying fulvate fractions for use in the manufacture of said compositions.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: November 21, 2017
    Assignee: Omni Bioceutical Innovations, Inc.
    Inventors: Gary W. Black, Jane Christensen, Farhan Taghizadeh